CMT Research Foundation Reception

February 23, 2024

6:30 p.m.

Naples, FL


Please join the CMT community for an informational and motivational evening celebrating the success of CMT drug development.

Dr. Arthur Suckow from DTx Pharma and Dr. Mario Saporta from the University of Miami will discuss what the future looks like for people living with Charcot-Marie-Tooth.

Guest Speakers

Dr. Arthur T. Suckow

Arthur T. Suckow, PhD, received his bachelor’s degree from the University of Delaware and his PhD from the University of California, San Diego. He has worked for Johnson & Johnson, AstraZeneca, and Regulus Therapeutics. Dr. Suckow’s extensive experience in fatty acid pharmacology includes advancing small molecules targeting fatty acids and fatty-acid conjugated peptides into early clinical development. Dr. Suckow has received numerous awards, including a Beckman Fellowship, NSF graduate research fellowship, a BIOCOM catalyst award, and many others.

Dr. Mario Saporta

Dr. Mario Saporta is a clinician-scientist and Associate Professor of Neurology and Human Genetics at the University of Miami Miller School of Medicine. He is the Medical Director of the University of Miami CMT Center of Excellene and MDA Care Center. Dr. Saporta conducts both clinical and translational research in genetic peripheral neuropathies. He is the North America Principal Investigator for the Pharnext Premier trial in CMT1A and leads a research lab focused on drug discovery and genetic therapy development for peripheral neuropathies using human induced pluripotent stem cell models. Dr. Saporta received his MBA in Health Management from Fundação Getulio Varges, and his PhD in Neuroscience, his MD in Neurology, and his MD from the Universidade Federal do Rio de Janeiro.

Questions about the event?

Please call 404-806-7180 or email [email protected]

We hope to see you there!


4062 Peachtree Road
Suite A209
Atlanta, GA 30319

Phone Number


Media Inquiries

George Simpson


[email protected]